Christopher M. Polley

Array ( [id] => 16298100 [patent_doc_number] => 20200283823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => TAGGING NUCLEIC ACIDS FOR SEQUENCE ASSEMBLY [patent_app_type] => utility [patent_app_number] => 16/685855 [patent_app_country] => US [patent_app_date] => 2019-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64595 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18182525 [patent_doc_number] => 20230043255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => FUSOSOME COMPOSITIONS FOR T CELL DELIVERY [patent_app_type] => utility [patent_app_number] => 17/293802 [patent_app_country] => US [patent_app_date] => 2019-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 123294 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17292540 [patent_doc_number] => 20210388379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => MODIFIED CLOSED-ENDED DNA (CEDNA) COMPRISING SYMMETRICAL MODIFIED INVERTED TERMINAL REPEATS [patent_app_type] => utility [patent_app_number] => 17/290787 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17336386 [patent_doc_number] => 20220002717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => PROGRAMMABLE NUCLEASES AND BASE EDITORS FOR MODIFYING NUCLEIC ACID DUPLEXES [patent_app_type] => utility [patent_app_number] => 17/290968 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17207761 [patent_doc_number] => 11168120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-09 [patent_title] => Methods and reagents for treatment of age-related macular degeneration [patent_app_type] => utility [patent_app_number] => 16/676145 [patent_app_country] => US [patent_app_date] => 2019-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 53536 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16676145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18933396 [patent_doc_number] => 11885813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Methods of diagnosing and predicting renal disease [patent_app_type] => utility [patent_app_number] => 16/671256 [patent_app_country] => US [patent_app_date] => 2019-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 13 [patent_no_of_words] => 9396 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16671256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16269193 [patent_doc_number] => 20200270680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => METHODS FOR ANALYZING NUCLEIC ACID SEQUENCES [patent_app_type] => utility [patent_app_number] => 16/671979 [patent_app_country] => US [patent_app_date] => 2019-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38847 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16671979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19731254 [patent_doc_number] => 12209245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-28 [patent_title] => Synthetic gene clusters [patent_app_type] => utility [patent_app_number] => 16/671036 [patent_app_country] => US [patent_app_date] => 2019-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 93 [patent_figures_cnt] => 51 [patent_no_of_words] => 24487 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16671036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16704590 [patent_doc_number] => 10954511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-23 [patent_title] => HTP genomic engineering platform for improving fungal strains [patent_app_type] => utility [patent_app_number] => 16/600062 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 88 [patent_no_of_words] => 100781 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15816921 [patent_doc_number] => 10633627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Instruments, modules, and methods for improved detection of edited sequences in live cells [patent_app_type] => utility [patent_app_number] => 16/597831 [patent_app_country] => US [patent_app_date] => 2019-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 78 [patent_no_of_words] => 56026 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15557353 [patent_doc_number] => 20200063088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS [patent_app_type] => utility [patent_app_number] => 16/597826 [patent_app_country] => US [patent_app_date] => 2019-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15342753 [patent_doc_number] => 20200009268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => EXPRESSION CONSTRUCTS AND SYSTEMS FOR SYSTEMIC AND NON-SPECIFIC IN VIVO DELIVERY OF A NUCLEIC ACID TO HUMAN CELLS AND TRANSIENT TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN [patent_app_type] => utility [patent_app_number] => 16/583197 [patent_app_country] => US [patent_app_date] => 2019-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14627 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16583197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18871379 [patent_doc_number] => 11859168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Electroporation, developmentally-activated cells, pluripotent-like cells, cell reprogramming and regenerative medicine [patent_app_type] => utility [patent_app_number] => 16/579889 [patent_app_country] => US [patent_app_date] => 2019-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 52 [patent_no_of_words] => 38869 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16579889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18871379 [patent_doc_number] => 11859168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Electroporation, developmentally-activated cells, pluripotent-like cells, cell reprogramming and regenerative medicine [patent_app_type] => utility [patent_app_number] => 16/579889 [patent_app_country] => US [patent_app_date] => 2019-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 52 [patent_no_of_words] => 38869 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16579889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17414328 [patent_doc_number] => 20220049232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => TRANSCRIPTIONAL RECORDING BY CRISPR SPACER ACQUISITION FROM RNA [patent_app_type] => utility [patent_app_number] => 17/274443 [patent_app_country] => US [patent_app_date] => 2019-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20963 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17467824 [patent_doc_number] => 11274294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-15 [patent_title] => TAL effector-mediated DNA modification [patent_app_type] => utility [patent_app_number] => 16/553550 [patent_app_country] => US [patent_app_date] => 2019-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 78 [patent_no_of_words] => 31246 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15978499 [patent_doc_number] => 10669559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => CRISPR enabled multiplexed genome engineering [patent_app_type] => utility [patent_app_number] => 16/551517 [patent_app_country] => US [patent_app_date] => 2019-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 25 [patent_no_of_words] => 9614 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16551517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18504872 [patent_doc_number] => 11702677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-18 [patent_title] => CRISPR enabled multiplexed genome engineering [patent_app_type] => utility [patent_app_number] => 16/550092 [patent_app_country] => US [patent_app_date] => 2019-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 25 [patent_no_of_words] => 9615 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16550092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18559947 [patent_doc_number] => 11725183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => Method of culturing segmented filamentous bacteria in vitro [patent_app_type] => utility [patent_app_number] => 16/548280 [patent_app_country] => US [patent_app_date] => 2019-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 5 [patent_no_of_words] => 10734 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16548280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15527773 [patent_doc_number] => 20200056192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => DETECTION OF NUCLEASE EDITED SEQUENCES IN AUTOMATED MODULES AND INSTRUMENTS VIA BULK CELL CULTURE [patent_app_type] => utility [patent_app_number] => 16/540767 [patent_app_country] => US [patent_app_date] => 2019-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16540767 [rel_patent_id] =>[rel_patent_doc_number] =>)